A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease. (2014)
Attributed to:
A systematic investigation into the pathogenesis and course of Parkinson's syndrome
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/ana.24188
PubMed Identifier: 24853080
Publication URI: http://europepmc.org/abstract/MED/24853080
Type: Journal Article/Review
Volume: 76
Parent Publication: Annals of neurology
Issue: 2
ISSN: 0364-5134